• Molecular NameChlorphenesin
  • Synonymalpha-Glyceryl ether; Chlorophenesin; Chlorphenesine [INN-French]; Chlorphenesinum [INN-Latin]; Clorfenesina [INN-Spanish]; p-Chlorophenyl; p-Chlorophenyl glyceryl ether
  • Weight202.637
  • Drugbank_IDDB00856
  • ACS_NO104-29-0
  • Show 3D model
  • LogP (experiment)1.606
  • LogP (predicted, AB/LogP v2.0)1.41
  • pkaN/A
  • LogD (pH=7, predicted)1.41
  • Solubility (experiment)10 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.77
  • LogSw (predicted, AB/LogsW2.0)2.38
  • Sw (mg/ml) (predicted, ACD/Labs)3.42
  • No.of HBond Donors2
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds4
  • TPSA49.69
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA centrally acting muscle relaxant used to treat muscle pain and spasms.
  • Absorption_value100.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic. 85% of a dose excreted within 24 hours as the glucuronide metabolite.
  • Half life2.3~5 hours
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of a chlorphenesin overdose include drowsiness and nausea.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A